Advanced Therapies 2021 | The ISCT’s ongoing battle against unproven cell & gene therapies

Miguel Forte, MD, PhD, Bone Therapeutics SA, Gosselies, Belgium, discusses the efforts being made by the International Society for Cell & Gene Therapy (ISCT) to tackle the use of unproven cell- and gene-based therapies. He discusses the ISCT’s alignment with regulators such as the US Food and Drug Administration (FDA) and their actions against developers treating patients with unvalidated products that are marketed with unsubstantiated claims. He also highlights the importance of the growing role the cell and gene therapy industry in the translation of products to patients. This interview took place at the Advanced Therapies Congress & Expo 2021.